1 "levels in systemic lupus erythematosus" 220-223, 1994
2 "The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease" 420 : 78-84, 2002
3 "Systemic lupus erythematosus: a model for atherogenesis?" 39 : 353-359, 2000
4 "Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect" 20 : 429-437, 2002
5 "Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities" 337 : 1360-1369, 1997
6 "Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus" 21 : 520-524, 2002
7 "Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus" 42 : 51-60, 1999
8 "Premature morbidity form cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus" 42 : 338-346, 1999
9 "Lipid profiles in the patients with systemic lupus erythematosus" 21 : 1264-1267, 1994
10 "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men" 336 : 973-979, 1997
1 "levels in systemic lupus erythematosus" 220-223, 1994
2 "The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease" 420 : 78-84, 2002
3 "Systemic lupus erythematosus: a model for atherogenesis?" 39 : 353-359, 2000
4 "Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect" 20 : 429-437, 2002
5 "Shattuck lecture: cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities" 337 : 1360-1369, 1997
6 "Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus" 21 : 520-524, 2002
7 "Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus" 42 : 51-60, 1999
8 "Premature morbidity form cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus" 42 : 338-346, 1999
9 "Lipid profiles in the patients with systemic lupus erythematosus" 21 : 1264-1267, 1994
10 "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men" 336 : 973-979, 1997
11 "Inflammation and immune responses in atherosclerosis" 23 : 535-541, 2002
12 "Inflammation and coronary artery disease" 331 : 468-469, 1994
13 "Inflammation and atherosclerosis" 105 : 1135-1143, 2002
14 "Immune mechanisms in atherosclerosis" 21 : 1876-1890, 2001
15 "HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL, a factor in its decrease" 37 : 2662-2674, 1996
16 "Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge" 499-502, 1972
17 "Effect of anti-rheumatic therapy on lipid profile in patients with rheumatoid arthritis: a prospective study" 113 : 188-193, 2002
18 "Chylomicron metabolism is markedly altered in systemic lupus erythematosus" 43 : 1033-1040, 2000
19 "C-reactive protein adds to the predictive value of total and HDL cholesterol in determing risk of first myocardial infarction" 97 : 2007-2011, 1998
20 "Atherosclerosis: an inflammatory disease" 340 : 115-126, 1999
21 "Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study" 145 : 408-415, 1997
22 "Accelerated atherogenesis in autoimmune rhematic disease" 1 : 338-347, 2002